We are live on ! Find out more
EFMH

E Fund Management (HK) Portfolio holdings

AUM $302M
1-Year Est. Return 64.42%
This Fund
S&P 500
This Quarter Est. Return
-13.63%
1 Year Est. Return
+64.42%
3 Year Est. Return
+162.67%
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
-$19M
Cap. Flow
+$7.39M
Cap. Flow %
5.87%
Top 10 Hldgs %
78.65%
Holding
33
New
3
Increased
10
Reduced
13
Closed
2

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$6.85M
2
PDD icon
Pinduoduo
PDD
+$2.76M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.87M
4
BZ icon
Kanzhun
BZ
+$1.49M
5
YMM icon
Full Truck Alliance
YMM
+$1.14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 63.16%
2 Real Estate 8.91%
3 Healthcare 8.02%
4 Communication Services 6.18%
5 Industrials 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQD icon
26
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
$809K 0.64%
7,900
IQ icon
27
iQIYI
IQ
$1.21B
$627K 0.5%
231,396
-1,088
-0.5% -$4.03K
HCM icon
28
HUTCHMED
HCM
$1.93B
$522K 0.41%
58,861
TSLA icon
29
Tesla
TSLA
$1.21T
$354K 0.28%
+1,335
New +$373K
STNG icon
30
Scorpio Tankers
STNG
$3.94B
$274K 0.22%
+6,508
New +$259K
JD icon
31
JD.com
JD
$42.9B
$72K 0.06%
1,424
CHIR
32
DELISTED
Global X MSCI China Real Estate ETF
CHIR
-1,806
Closed -$55K
DIDI
33
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
-2,203,522
Closed -$6.5M

Similar funds

E Fund Management (HK)'s Q3 2022 Portfolio in Review

As of Q3 2022, E Fund Management (HK) held 33 positions worth $126M, down 13% from $145M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

E Fund Management (HK) deployed $7.39M of net new capital in Q3 2022, opening 3 new positions and adding to 10 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 6,500 shares worth $1.88M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, down from 65% a quarter earlier, followed by Real Estate and Healthcare.

On the sell side, the largest reduction was Lufax Holding, an estimated $477K trimmed.

  • E Fund Management (HK)'s largest Q3 2022 buy was Vertex Pharmaceuticals: 6,500 shares worth $1.88M.
  • E Fund Management (HK) added most to KE Holdings in Q3 2022, an estimated $6.85M increase.
  • E Fund Management (HK)'s biggest Q3 2022 reduction was Lufax Holding, cutting an estimated $477K.
  • E Fund Management (HK) fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q3 2022, selling an estimated $6.5M.
  • E Fund Management (HK)'s ten largest holdings make up 79% of its $126M portfolio in Q3 2022.
  • E Fund Management (HK) opened 3 new positions and closed 2 in Q3 2022.
  • E Fund Management (HK)'s portfolio value fell 13% quarter-over-quarter to $126M.

Based on E Fund Management (HK)'s 13F filing for Q3 2022, filed 24 Oct 2022.